Skip to main content

Craig B. Thompson, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get REGN alerts

About Craig B. Thompson, M.D.

Craig B. Thompson, M.D. is recorded as Board Member at Regeneron Pharmaceuticals, Inc. (REGN) since October 3, 2022. Regeneron Pharmaceuticals, Inc. reported in an 8-K filed October 3, 2022 that Craig B. Thompson, M.D. was appointed director, effective October 3, 2022. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.

“On October 3, 2022, the board of directors (the "Board") of Regeneron Pharmaceuticals, Inc. (the "Company") elected Craig B. Thompson, M.D. as a director.”
Regeneron Pharmaceuticals, Inc. Form 8-K, filed October 3, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Regeneron Pharmaceuticals, Inc.

Recent activity